ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Recurrence"

  • 2018 American Transplant Congress

    Preemptive Rituximab in Focal and Segmental Glomerulosclerosis Patients at Risk for Recurrence after Transplantation

    P. Auñon,1 N. Polanco,1 M. Perez,2 E. Rodrigo,3 A. Sancho,4 J. Pascual,2 A. Andres,1 M. Praga.1

    1Nephrology Department, Hospital Doce de Octubre, Madrid, Spain; 2Nephrology Department, Hospital del Mar, Barcelona, Spain; 3Nephrology Department, Hospital Marques de Valdecilla, Santander, Spain; 4Nephrology Department, Hospital Doctor Peset, Valencia, Spain.

    INTRODUCTIONRecurrence of focal and segmental glomerulosclerosis (FSGS) after renal transplantation is a characteristic complication of the disease that occurs in one third of the cases.…
  • 2018 American Transplant Congress

    Durable Donor Hematopoetic Stem Cell (HSC) Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined HSC/Kidney Transplants

    J. Leventhal,1 L. Gallon,1 J. Mathew,1 J. Miller,1 D. Stare,1 S. Ildstad.2

    1Northwestern U, Chicago; 2U Louisville, Louisville.

    Recurrence of the original cause of ESRD has been observed in trials of tolerance induction for kidney transplantation (KTx) where donor HSC have been used…
  • 2018 American Transplant Congress

    Graft Failure in Recurrent IgA Nephropathy Following Living Kidney Transplantation: Predictive Factors Analysis of 102 Biopsies

    J. Zhang, J. Qiu, G. Chen, C. Wang, L. Chen.

    Organ Transplant Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Aim To investigate the predictive factors related to graft failure in recurrentIgA nephropathy (IgAN) following living kidney transplantation. Methods We identified a series of 102…
  • 2018 American Transplant Congress

    FSGS Recurrence and Graft Survival in Pediatric Renal Transplants: A NAPRTCS Registry Analysis

    L. Koh,1 K. Martz,2 T. Blydt-Hansen.3

    1Starship Children's Health, Auckland, New Zealand; 2EMMES Corp., Rockville; 3BC Children's Hospital, Vancouver, Canada.

    IntroductionPrevious studies have raised concern of adverse outcome of living donor (LD) grafts in children transplanted for FSGS. This study reassesses impact of donor source,…
  • 2018 American Transplant Congress

    Validating MORAL in Living Donor Liver Transplantation for Hepatocellular Carcinoma

    A. Bhatti, A. Qureshi, N. Khan, M. Butt, A. Waheed, A. Rana, F. Dar.

    Hepatobiliary Surgery and Liver Transplantation, Hepatology, Radiology, Shifa International Hospital, Islamabad, Pakistan.

    The “Model of Recurrence after Liver Transplant” (MORAL) study has identified certain pre and post operative variables that have significant impact on recurrence free survival…
  • 2018 American Transplant Congress

    Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis

    K. Yoon, K. Lee, S. Hong, J-.H. Cho, J-.M. Lee, N-.J. Yi, K. Suh.

    Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

    Introduction: Liver transplantation(LT) has better outcomes even in patient with child A than LR because LT can overcome the tumor and background liver factors. We…
  • 2018 American Transplant Congress

    FSGS Pattern with Podocyte Proliferation and Heavy Proteinuria Combined Late Antibody Mediated Rejection of Renal Allograft: Collapsing Glomerulopathy or Transplant Podocytopathy?

    J. Wen, M. Zhang, F. Xu, J. Chen, D. Cheng, X. Ni, X. Li.

    National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.

    Background: Collapsing Glomerulopathy is a pathologically and clinically distinct variant of FSGS with poor prognosis.Hemodynamic disturbances may play a role in the development of the…
  • 2018 American Transplant Congress

    Preemptive Plasma Therapy and Eculizumab (ECU) Rescue for Atypical Hemolytic Uremic Syndrome (aHUS) Relapse Following Kidney Transplantation (KTX)

    C. Aigner,1,2 G. Böhmig,1 F. Eskandary,1 M. Gaggl,1 R. Kain,2 R. Sunder-Plassmann,3 Z. Prohaszka,4 A. Schmidt,1 G. Sunder-Plassmann.1

    1Division of Nephrology and Dialysis, Medical University Vienna, Vienna, Austria; 2Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria; 3Department of Laboratory Medicine, Medical University Vienna, Vienna, Austria; 43rd Department of Medicine, Semmelweis University, Budapest, Hungary.

    Introduction: KTX in aHUS patients is associated with a high rate of relapse and graft loss. Here, we report on seven aHUS cases with end-stage…
  • 2017 American Transplant Congress

    Outcome and Risk Factors of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation.

    G. Chen, C. Wang, Z. Wu, J. Zhang, S. Yu, C. Wang, J. Qiu, L. Chen.

    Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Background Recurrent focal segmental glomerulosclerosis(FSGS) is common after kidney transplantation . We conducted a retrospective cohort study with the aim to investigating the long-term outcome…
  • 2017 American Transplant Congress

    Predictive Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy After Kidney Transplantation.

    N. Maillard,1 H. Suzuki,2 H. Mohey,1 C. Mariat,1 J. Novak,3 B. Julian,4 F. Berthoux.1

    1Nephrology, Dialysis and Renal Transplantation, CHU Saint Etienne, Saint Etienne, France; 2Division of Nephrology, Department of Internal Medicine, Juntendo University, Tokyo, Japan; 3Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL; 4Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

    The recurrence of IgA nephropathy (IgAN) after kidney transplantation is frequent and can cause graft losses. The prediction of the recurrence cannot be performed from…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences